FDAFDA · Food and drugs·Recall number D-0788-2022
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.
Published May 4, 2022 · Recall initiated: April 6, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- LOSARTAN POTASSIUM
- Manufacturer
- RemedyRepack Inc.
- Distributor
- Product was distributed to customers in AK and PA.
- Lot
- Lot # B1467803-120621, exp. date 06/30/2022 Lot # J0585793-121721, exp. date 12/31/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.